FutureTech II Acquisition Corp. FTII
12.02 USD 0.00 (+0.00%)
At closeFeb 5, 2026, 4:00 PM EST
12.02 Day range 12.02
12.02 52-week range 12.02
- YTD
- 0.00%
- 1 year
- +2.74%
- Market cap
- 48.82M
- EPS (ttm)
- -0.42
- Shares out
- 4.26M
- YTD return
- 0.00%
- 1-year return
- +2.74%
- Volume
- 1
- Open
- 12.02
- Previous close
- 12.02
- Day's range
- 12.02 – 12.02
- 52-week range
- 12.02 – 12.02
- Beta
- -0.00
No chart data for this range yet.
Key statistics
- Enterprise value
- 65.58M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 818.33K
- Total cash
- 476
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.05%
- 50-day average
- 11.14
- 200-day average
- 11.11
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
FTII Revenue — quarterly 0
FTII Net income — quarterly -123.13K
FTII EPS — quarterly -0.07
About FutureTech II Acquisition Corp.
FutureTech II Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on business operating in the technology industry, including artificial intelligence (AI), robotic process automation, and other related technology market. FutureTech II Acquisition Corp. was founded in 2021 and is based in New Rochelle, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
News
FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance 
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
Your note
Sign in to keep a note on FTII — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Calamos Advisors LLC | 9.00% | 500,000 | 5.63M | Sep 29, 2024 |
| Clear Street LLC | 4.02% | 223,139 | 2.51M | Sep 29, 2024 |
| Hudson Bay Capital Management Lp | 3.60% | 200,000 | 2.25M | Sep 29, 2024 |
| Walleye Capital LLC | 2.54% | 141,355 | 1.59M | Sep 29, 2024 |
| Cowen and Company, LLC | 2.20% | 121,980 | 1.37M | Sep 29, 2024 |
| Berkley W R Corp | 1.80% | 99,739 | 1.12M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Calamos Market Neutral Income Fund | 9.00% | 500,000 | 5.63M | Oct 30, 2024 |
| RiverNorth Opportunities Fd | 0.56% | 30,880 | 347.40K | Sep 29, 2024 |
| First Tr Exchange Traded Fd-First Trust Alternative Opportunities Fd | 0.36% | 20,000 | 225.00K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.02% | 943 | 10.61K | Oct 30, 2024 |